Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

generic medicines

  1. Home>
  2. News>
  3. generic medicines>
  4. Page 24

India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026

  • Post published:July 3, 2026
  • Post category:Knowledge

India's reputation as the "Pharmacy of the World" rests on its ability to produce high-quality generic medicines at affordable prices. However, the past few years have exposed serious quality challenges…

Continue Reading India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026

India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise

  • Post published:July 2, 2026
  • Post category:News

India's pharmaceutical sector continues to strengthen its global position with a series of positive developments in mid-2026. From extending its lead over China in US FDA drug master filings to…

Continue Reading India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise

Understanding CDSCO’s Generic Drug Approval Process: A 2026 Guide for Buyers

  • Post published:July 1, 2026
  • Post category:Knowledge

India's Central Drugs Standard Control Organization (CDSCO) is the national regulatory authority responsible for approving, monitoring, and regulating pharmaceutical products in the country. For international buyers seeking high-quality generic medicines…

Continue Reading Understanding CDSCO’s Generic Drug Approval Process: A 2026 Guide for Buyers

US-India Trade Deal Very Close: Indian Generics Sector Gains Edge

  • Post published:June 29, 2026
  • Post category:News

The long-anticipated US-India bilateral trade deal is moving toward finalization, with major implications for India's generic pharmaceutical industry. US President Donald Trump confirmed at the G7 summit in Évian, France…

Continue Reading US-India Trade Deal Very Close: Indian Generics Sector Gains Edge
  • Go to the previous page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 31
  • Go to the next page

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
    November 14, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide
  • India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve